Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. 5 steps to medical device cybersecurity, from Microsoft’s U.K. security chief
Protecting medical devices from malware and viruses means practicing good cybersecurity "hygiene," Microsoft’s U.K. chief security advisor says.
6. TAVI: Medtronic’s next-gen Engager looks good in 1st pivotal study results
Medtronic’s next-generation Engager transcatheter aortic valve implantation system appears to reduce valve leakage and offer simpler delivery than 1st-generation devices.
5. Allergan may sell Lap-Band business
Third-quarter profits for Allergan tick down on a 6.4% sales increase as the medical aesthetics company tightens its outlook for the rest of the year
4. sBioMed taps ex-Stryker CEO MacMillan as CEO
Former Stryker CEO Stephen MacMillan tells MassDevice.com about his new gig: CEO and part-owner of sBioMed, which makes infection control products.
3. Zimmer pulls metal-on-metal Durom acetabular hip implants from Australian market
Orthopedic devices giant Zimmer cancels its Durom acetabular hip implant component from the Australian market amid higher revision rates.
2. St. Jude lays off another 500 amid ongoing company-wide overhaul
St. Jude Medical plans to lay off an additional 500 employees as it restructures its product divisions into 2 new units, focusing on cardiovascular and ablation technologies and implantable electronics.
1. Boston Scientific’s new CEO takes the reins
Michael Mahoney can finally remove the "incoming" from his title as he officially takes over the corner office at medical device company Boston Scientific.
